AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
5min chapter
342: FDA cuts, zombie biotechs, and too much weight loss?
The Readout Loud
Optimism in Gene Therapy Development
This chapter explores the hopeful outlook of pharmaceutical leaders regarding the Trump administration amidst industry cuts, and highlights Solid Biosciences' promising advancements in gene therapy for Duchenne muscular dystrophy. It reflects on the company's resilience through past challenges while navigating a competitive landscape for effective treatment options.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode